Background Diabetic kidney disease (DKD) is recognized as a significant complication of diabetes mellitus and categorized into glomerular DKDs and tubular DKDs, each governed by distinct pathological mechanisms and biomarkers.
Methods Through the identification of common features observed in glomerular and tubular lesions in DKD, numerous differentially expressed gene were identified by the machine learning, single-cell transcriptome and mendelian randomization.
Results The diagnostic markers versican (VCAN) was identified, offering supplementary options for clinical diagnosis. VCAN significantly highly expressed in glomerular parietal epithelial cell and proximal convoluted tubular cell. It was mainly involved in the up-regulation of immune genes and infiltration of immune cells like mast cell. Mendelian randomization analysis confirmed that serum VCAN protein levels were a risky factor for DKD, while there was no reverse association. It exhibited the good diagnostic potential for estimated glomerular filtration rate and proteinuria in DKD.
Conclusion VCAN showed the prospects into DKD pathology and clinical indicator.
Globally, the number of people with diabetes mellitus has quadrupled in the past three decades, and approximately one in 11 adults worldwide have diabetes mellitus. Since both microvascular and macrovascular diseases in patients with diabetes predispose them to a lower quality of life as well as higher rates of mortality, managing blood glucose levels is of clinical relevance in diabetes care. Many classes of antihyperglycemic drugs are currently approved to treat hyperglycemia in patients with type 2 diabetes mellitus, with several new drugs having been developed during the last decade. Diabetes-related complications have been reduced substantially worldwide. Prioritization of therapeutic agents varies according to national guidelines. However, since the characteristics of participants in clinical trials differ from patients in actual clinical practice, it is difficult to apply the results of such trials to clinical practice. Machine learning approaches became highly topical issues in medicine along with rapid technological innovations in the fields of information and communication in the 1990s. However, adopting these technologies to support decision-making regarding drug treatment strategies for diabetes care has been slow. This review summarizes data from recent studies on the choice of drugs for type 2 diabetes mellitus focusing on machine learning approaches.
Citations
Citations to this article as recorded by
Improving Clinical Preparedness: Community Health Nurses and Early Hypoglycemia Prediction in Type 2 Diabetes Using Hybrid Machine Learning Techniques Sachin Ramnath Gaikwad, Mallikarjun Reddy Bontha, Seeta Devi, Dipali Dumbre Public Health Nursing.2025; 42(1): 286. CrossRef
Empowerment in Type 2 diabetes: A patient-centred approach for lifestyle change Charlotte Björk Ingul, Siri Marte Hollekim-Strand, Mari Mørkeset Sandbakk, Torunn Ingfrid Grønseth, Tone Iren K. Rånes, Lars Tung Dyrendahl, Katarina Eilertsen, Stephan Kristensen, Turid Follestad, Bjarte Bye Løfaldli Diabetes Research and Clinical Practice.2025; 220: 111998. CrossRef
Exploring antioxidant activities and inhibitory effects against α‐amylase and α‐glucosidase of Elaeocarpus braceanus fruits: insights into mechanisms by molecular docking and molecular dynamics Hong Li, Yuanyue Zhang, Zhijia Liu, Chaofan Guo, Maurizio Battino, Shengbao Cai, Junjie Yi International Journal of Food Science & Technology.2024; 59(1): 343. CrossRef
3D Convolutional Neural Networks for Predicting Protein Structure for Improved Drug Recommendation Pokkuluri Kiran Sree, SSSN Usha Devi N EAI Endorsed Transactions on Pervasive Health and Technology.2024;[Epub] CrossRef
Artificial Intelligence in Plastic Surgery: Advancements, Applications, and Future Tran Van Duong, Vu Pham Thao Vy, Truong Nguyen Khanh Hung Cosmetics.2024; 11(4): 109. CrossRef
Background There are many models for predicting diabetes mellitus (DM), but their clinical implication remains vague. Therefore, we aimed to create various DM prediction models using easily accessible health screening test parameters.
Methods Two sets of variables were used to develop eight DM prediction models. One set comprised 62 easily accessible examination results of commonly used variables from a tertiary university hospital. The second set comprised 27 of the 62 variables included in the national routine health checkups. Gradient boosting and random forest algorithms were used to develop the models. Internal validation was performed using the stratified 10-fold cross-validation method.
Results The area under the receiver operating characteristic curve (ROC-AUC) for the 62-variable DM model making 12-month predictions for subjects without diabetes was the largest (0.928) among those of the eight DM prediction models. The ROC-AUC dropped by more than 0.04 when training with the simplified 27-variable set but still showed fairly good performance with ROC-AUCs between 0.842 and 0.880. The accuracy was up to 11.5% higher (from 0.807 to 0.714) when fasting glucose was included.
Conclusion We created easily applicable diabetes prediction models that deliver good performance using parameters commonly assessed during tertiary university hospital and national routine health checkups. We plan to perform prospective external validation, hoping that the developed DM prediction models will be widely used in clinical practice.
Citations
Citations to this article as recorded by
Artificial intelligence applied to diabetes complications: a bibliometric analysis Yukun Tao, Jinzheng Hou, Guangxin Zhou, Da Zhang Frontiers in Artificial Intelligence.2025;[Epub] CrossRef
Predictive modeling for the development of diabetes mellitus using key factors in various machine learning approaches Marenao Tanaka, Yukinori Akiyama, Kazuma Mori, Itaru Hosaka, Kenichi Kato, Keisuke Endo, Toshifumi Ogawa, Tatsuya Sato, Toru Suzuki, Toshiyuki Yano, Hirofumi Ohnishi, Nagisa Hanawa, Masato Furuhashi Diabetes Epidemiology and Management.2024; 13: 100191. CrossRef
Validation of the Framingham Diabetes Risk Model Using Community-Based KoGES Data Hye Ah Lee, Hyesook Park, Young Sun Hong Journal of Korean Medical Science.2024;[Epub] CrossRef
Integrated Embedded system for detecting diabetes mellitus using various machine learning techniques Rishita Konda, Anuraag Ramineni, Jayashree J, Niharika Singavajhala, Sai Akshaj Vanka EAI Endorsed Transactions on Pervasive Health and Technology.2024;[Epub] CrossRef
Predicting diabetes in adults: identifying important features in unbalanced data over a 5-year cohort study using machine learning algorithm Maryam Talebi Moghaddam, Yones Jahani, Zahra Arefzadeh, Azizallah Dehghan, Mohsen Khaleghi, Mehdi Sharafi, Ghasem Nikfar BMC Medical Research Methodology.2024;[Epub] CrossRef
Use of Machine Learning to Predict the Incidence of Type 2 Diabetes Among Relatively Healthy Adults: A 10-Year Longitudinal Study in Taiwan Ying-Qiang Liu, Tzu-Wei Chang, Lung-Chun Lee, Chia-Yu Chen, Pi-Shan Hsu, Yu-Tse Tsan, Chao-Tung Yang, Wei-Min Chu Diagnostics.2024; 15(1): 72. CrossRef
The Present and Future of Artificial Intelligence-Based Medical Image in Diabetes Mellitus: Focus on Analytical Methods and Limitations of Clinical Use Ji-Won Chun, Hun-Sung Kim Journal of Korean Medical Science.2023;[Epub] CrossRef
Machine learning for predicting diabetic metabolism in the Indian population using polar metabolomic and lipidomic features Nikita Jain, Bhaumik Patel, Manjesh Hanawal, Anurag R. Lila, Saba Memon, Tushar Bandgar, Ashutosh Kumar Metabolomics.2023;[Epub] CrossRef
Retrospective cohort analysis comparing changes in blood glucose level and body composition according to changes in thyroid‐stimulating hormone level Hyunah Kim, Da Young Jung, Seung‐Hwan Lee, Jae‐Hyoung Cho, Hyeon Woo Yim, Hun‐Sung Kim Journal of Diabetes.2022; 14(9): 620. CrossRef
Improving Machine Learning Diabetes Prediction Models for the Utmost Clinical Effectiveness Juyoung Shin, Joonyub Lee, Taehoon Ko, Kanghyuck Lee, Yera Choi, Hun-Sung Kim Journal of Personalized Medicine.2022; 12(11): 1899. CrossRef